Summary

Definition and Scope:
Natural killer (NK) cell therapy is an emerging form of immunotherapy that leverages the innate cytotoxic abilities of NK cells to target and eliminate cancer cells, infected cells, or other abnormal cells without prior sensitization. Unlike T-cell therapies, NK cells do not require human leukocyte antigen (HLA) matching, reducing the risk of graft-versus-host disease (GVHD) and enabling off-the-shelf applications. These therapies can be derived from various sources, including peripheral blood, umbilical cord blood, induced pluripotent stem cells (iPSCs), or engineered NK cell lines, and are often enhanced through genetic modifications or cytokine stimulation to improve persistence, targeting, and tumor-killing efficiency. NK cell therapy is being explored for hematologic malignancies, solid tumors, and infectious diseases, with clinical trials demonstrating promising safety profiles and efficacy in early-phase studies. The market is driven by increasing investment in cell-based immunotherapies, advancements in genetic engineering, and the growing demand for alternatives to conventional cancer treatments. However, challenges such as manufacturing scalability, limited persistence in vivo, and tumor microenvironment resistance remain key hurdles for broader commercialization. Major pharmaceutical companies, biotech firms, and academic institutions are actively involved in developing next-generation NK cell therapies, with partnerships and licensing deals accelerating clinical translation. Regulatory approvals, particularly for allogeneic "off-the-shelf" products, will be critical in shaping the competitive landscape. The market is poised for significant growth as research progresses and combination strategies with checkpoint inhibitors, monoclonal antibodies, or other immunotherapies gain traction.
This report offers a comprehensive analysis of the global Natural Killer Cell Therapy market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.

The global Natural Killer Cell Therapy market size was estimated at USD 502.07 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 24.52% during the forecast period.

Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Natural Killer Cell Therapy market.

Global Natural Killer Cell Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest

Market Segmentation by Type
NK Cell Therapies
NK Cell Directed Antibodies

Market Segmentation by Application
Cancer
Gastrointestinal Diseases
Others

Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA

Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Natural Killer Cell Therapy Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapter 4: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 5: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 6: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 7: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapters 8: Regional Market Analysis by Consumption
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 9: Regional Market Analysis by Production
These chapters shares the main producing countries of Natural Killer Cell Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 12: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.

ページTOPに戻る

Table of Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Natural Killer Cell Therapy
1.2 Key Market Segments
1.2.1 Natural Killer Cell Therapy Segment by Type
1.2.2 Natural Killer Cell Therapy Segment by Application
1.3 Methodology & Sources of Information
2
3 Global Natural Killer Cell Therapy Market Overview
3.1 Global Natural Killer Cell Therapy Market Overview
3.1.1 Global Natural Killer Cell Therapy Market Size and Forecasts (2020-2035)
3.2 Market Segment Executive Summary
3.3 Global Market Size by Region
4 Natural Killer Cell Therapy Market Competitive Landscape
4.1 Company Assessment Quadrant
4.2 Global Natural Killer Cell Therapy Product Life Cycle
4.3 Global Natural Killer Cell Therapy Sales by Manufacturers (2020-2025)
4.4 Global Natural Killer Cell Therapy Revenue Market Share by Manufacturers (2020-2025)
4.5 Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Natural Killer Cell Therapy Average Price by Manufacturers (2020-2025)
4.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
4.8 Natural Killer Cell Therapy Market Competitive Situation and Trends
4.8.1 Natural Killer Cell Therapy Market Concentration Rate
4.8.2 Global 5 and 10 Largest Natural Killer Cell Therapy Players Market Share by Revenue
4.8.3 Mergers & Acquisitions, Expansion
5 Natural Killer Cell Therapy Industry Chain Analysis
5.1 Natural Killer Cell Therapy Industry Chain Analysis
5.2 Market Overview of Key Raw Materials
5.3 Midstream Market Analysis
5.4 Downstream Customer Analysis
6 The Development and Dynamics of Natural Killer Cell Therapy Market
6.1 Key Development Trends
6.2 Driving Factors
6.3 Market Challenges
6.4 Industry News
6.4.1 New Product Developments
6.4.2 Mergers & Acquisitions
6.4.3 Expansions
6.4.4 Collaboration/Supply Contracts
6.5 PEST Analysis
6.5.1 Political Environment Analysis
6.5.2 Economic Environment Analysis
6.5.3 Social Environment Analysis
6.5.4 Technological Environment Analysis
6.6 Global Natural Killer Cell Therapy Market Porter's Five Forces Analysis
6.6.1 Global Trade Frictions
6.6.2 U.S. Tariff Policy
6.6.3 Global Trade Frictions and Their Impacts on Natural Killer Cell Therapy Market
7 Natural Killer Cell Therapy Market Segmentation by Type
7.1 Evaluation Matrix of Segment Market Development Potential (Type)
7.2 Global Natural Killer Cell Therapy Sales Market Share by Type (2020-2025)
7.3 Global Natural Killer Cell Therapy Market Size by Type (2020-2025)
7.4 Global Natural Killer Cell Therapy Price by Type (2020-2025)
8 Natural Killer Cell Therapy Market Segmentation by Application
8.1 Evaluation Matrix of Segment Market Development Potential (Application)
8.2 Global Natural Killer Cell Therapy Market Sales by Application (2020-2025)
8.3 Global Natural Killer Cell Therapy Market Size (M USD) by Application (2020-2025)
8.4 Global Natural Killer Cell Therapy Sales Growth Rate by Application (2020-2025)
9 Natural Killer Cell Therapy Market Segmentation by Region
9.1 Global Natural Killer Cell Therapy Sales by Region
9.1.1 Global Natural Killer Cell Therapy Sales by Region
9.1.2 Global Natural Killer Cell Therapy Sales Market Share by Region
9.2 Global Natural Killer Cell Therapy Market Size by Region
9.2.1 Global Natural Killer Cell Therapy Market Size by Region
9.2.2 Global Natural Killer Cell Therapy Market Size by Region
9.3 North America
9.3.1 North America Natural Killer Cell Therapy Sales by Country
9.3.2 North America Natural Killer Cell Therapy Market Size by Country
9.3.3 U.S. Market Overview
9.3.4 Canada Market Overview
9.3.5 Mexico Market Overview
9.4 Europe
9.4.1 Europe Natural Killer Cell Therapy Sales by Country
9.4.2 Europe Natural Killer Cell Therapy Market Size by Country
9.4.3 Germany Market Overview
9.4.4 France Market Overview
9.4.5 U.K. Market Overview
9.4.6 Italy Market Overview
9.4.7 Spain Market Overview
9.5 Asia Pacific
9.5.1 Asia Pacific Natural Killer Cell Therapy Sales by Region
9.5.2 Asia Pacific Natural Killer Cell Therapy Market Size by Region
9.5.3 China Market Overview
9.5.4 Japan Market Overview
9.5.5 South Korea Market Overview
9.5.6 India Market Overview
9.5.7 Southeast Asia Market Overview
9.6 South America
9.6.1 South America Natural Killer Cell Therapy Sales by Country
9.6.2 South America Natural Killer Cell Therapy Market Size by Country
9.6.3 Brazil Market Overview
9.6.4 Argentina Market Overview
9.6.5 Columbia Market Overview
9.7 Middle East and Africa
9.7.1 Middle East and Africa Natural Killer Cell Therapy Sales by Region
9.7.2 Middle East and Africa Natural Killer Cell Therapy Market Size by Region
9.7.3 Saudi Arabia Market Overview
9.7.4 UAE Market Overview
9.7.5 Egypt Market Overview
9.7.6 Nigeria Market Overview
9.7.7 South Africa Market Overview
10 Natural Killer Cell Therapy Market Production by Region
10.1 Global Production of Natural Killer Cell Therapy by Region(2020-2025)
10.2 Global Natural Killer Cell Therapy Revenue Market Share by Region (2020-2025)
10.3 Global Natural Killer Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10.4 North America Natural Killer Cell Therapy Production
10.4.1 North America Natural Killer Cell Therapy Production Growth Rate (2020-2025)
10.4.2 North America Natural Killer Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10.5 Europe Natural Killer Cell Therapy Production
10.5.1 Europe Natural Killer Cell Therapy Production Growth Rate (2020-2025)
10.5.2 Europe Natural Killer Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10.6 Japan Natural Killer Cell Therapy Production (2020-2025)
10.6.1 Japan Natural Killer Cell Therapy Production Growth Rate (2020-2025)
10.6.2 Japan Natural Killer Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10.7 China Natural Killer Cell Therapy Production (2020-2025)
10.7.1 China Natural Killer Cell Therapy Production Growth Rate (2020-2025)
10.7.2 China Natural Killer Cell Therapy Production, Revenue, Price and Gross Margin (2020-2025)
11 Key Companies Profile
11.1 Nektar Therapeutics
11.1.1 Nektar Therapeutics Basic Information
11.1.2 Nektar Therapeutics Natural Killer Cell Therapy Product Overview
11.1.3 Nektar Therapeutics Natural Killer Cell Therapy Product Market Performance
11.1.4 Nektar Therapeutics Business Overview
11.1.5 Nektar Therapeutics SWOT Analysis
11.1.6 Nektar Therapeutics Recent Developments
11.2 Innate Pharma SA
11.2.1 Innate Pharma SA Basic Information
11.2.2 Innate Pharma SA Natural Killer Cell Therapy Product Overview
11.2.3 Innate Pharma SA Natural Killer Cell Therapy Product Market Performance
11.2.4 Innate Pharma SA Business Overview
11.2.5 Innate Pharma SA SWOT Analysis
11.2.6 Innate Pharma SA Recent Developments
11.3 Affimed
11.3.1 Affimed Basic Information
11.3.2 Affimed Natural Killer Cell Therapy Product Overview
11.3.3 Affimed Natural Killer Cell Therapy Product Market Performance
11.3.4 Affimed Business Overview
11.3.5 Affimed SWOT Analysis
11.3.6 Affimed Recent Developments
11.4 Chipscreen Biosciences
11.4.1 Chipscreen Biosciences Basic Information
11.4.2 Chipscreen Biosciences Natural Killer Cell Therapy Product Overview
11.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Product Market Performance
11.4.4 Chipscreen Biosciences Business Overview
11.4.5 Chipscreen Biosciences Recent Developments
11.5 Glycostem Therapeutics
11.5.1 Glycostem Therapeutics Basic Information
11.5.2 Glycostem Therapeutics Natural Killer Cell Therapy Product Overview
11.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Product Market Performance
11.5.4 Glycostem Therapeutics Business Overview
11.5.5 Glycostem Therapeutics Recent Developments
11.6 Fate Therapeutics
11.6.1 Fate Therapeutics Basic Information
11.6.2 Fate Therapeutics Natural Killer Cell Therapy Product Overview
11.6.3 Fate Therapeutics Natural Killer Cell Therapy Product Market Performance
11.6.4 Fate Therapeutics Business Overview
11.6.5 Fate Therapeutics Recent Developments
11.7 Dragonfly Therapeutics
11.7.1 Dragonfly Therapeutics Basic Information
11.7.2 Dragonfly Therapeutics Natural Killer Cell Therapy Product Overview
11.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Product Market Performance
11.7.4 Dragonfly Therapeutics Business Overview
11.7.5 Dragonfly Therapeutics Recent Developments
11.8 Kiadis Pharma
11.8.1 Kiadis Pharma Basic Information
11.8.2 Kiadis Pharma Natural Killer Cell Therapy Product Overview
11.8.3 Kiadis Pharma Natural Killer Cell Therapy Product Market Performance
11.8.4 Kiadis Pharma Business Overview
11.8.5 Kiadis Pharma Recent Developments
11.9 Nkarta Therapeutics
11.9.1 Nkarta Therapeutics Basic Information
11.9.2 Nkarta Therapeutics Natural Killer Cell Therapy Product Overview
11.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Product Market Performance
11.9.4 Nkarta Therapeutics Business Overview
11.9.5 Nkarta Therapeutics Recent Developments
11.10 NantKwest
11.10.1 NantKwest Basic Information
11.10.2 NantKwest Natural Killer Cell Therapy Product Overview
11.10.3 NantKwest Natural Killer Cell Therapy Product Market Performance
11.10.4 NantKwest Business Overview
11.10.5 NantKwest Recent Developments
12 Natural Killer Cell Therapy Market Forecast by Region
12.1 Global Natural Killer Cell Therapy Market Size Forecast
12.2 Global Natural Killer Cell Therapy Market Forecast by Region
12.2.1 North America Market Size Forecast by Country
12.2.2 Europe Natural Killer Cell Therapy Market Size Forecast by Country
12.2.3 Asia Pacific Natural Killer Cell Therapy Market Size Forecast by Region
12.2.4 South America Natural Killer Cell Therapy Market Size Forecast by Country
12.2.5 Middle East and Africa Natural Killer Cell Therapy Market Size Forecast by Country
13 Forecast Market by Type and by Application (2026-2035)
13.1 Global Natural Killer Cell Therapy Market Forecast by Type (2026-2035)
13.1.1 Global Forecasted Sales of Natural Killer Cell Therapy by Type (2026-2035)
13.1.2 Global Natural Killer Cell Therapy Market Size Forecast by Type (2026-2035)
13.1.3 Global Forecasted Price of Natural Killer Cell Therapy by Type (2026-2035)
13.2 Global Natural Killer Cell Therapy Market Forecast by Application (2026-2035)
13.2.1 Global Natural Killer Cell Therapy Sales (K Units) Forecast by Application
13.2.2 Global Natural Killer Cell Therapy Market Size (M USD) Forecast by Application (2026-2035)
14 Conclusion and Key Findings

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Natural Killer Cell Therapy Market Size by Type (M USD)
Table 4. Global Natural Killer Cell Therapy Market Size by Application
Table 5. Natural Killer Cell Therapy Market Size Comparison by Region (M USD)
Table 6. Natural Killer Cell Therapy Market Size by Country (M USD)
Table 7. Global Natural Killer Cell Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 8. Global Natural Killer Cell Therapy Sales Market Share by Manufacturers (2020-2025)
Table 9. Global Natural Killer Cell Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 10. Global Natural Killer Cell Therapy Revenue Share by Manufacturers (2020-2025)
Table 11. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer Cell Therapy as of 2025)
Table 12. Global Market Natural Killer Cell Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 13. Manufacturers’ Manufacturing Sites, Areas Served
Table 14. Manufacturers’ Product Type
Table 15. Global Natural Killer Cell Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Market Overview of Key Raw Materials
Table 18. Midstream Market Lists
Table 19. Downstream Customer Analysis
Table 20. Key Development Trends
Table 21. Driving Factors
Table 22. Natural Killer Cell Therapy Market Challenges
Table 23. World Bank's Forecast Real GDP Growth Rate for 2024-2028
Table 24. Goldman Sachs' Forecast Real GDP Growth Rate for 2025-2026
Table 25. IMF's Forecast Real GDP Growth Rate For 2024-2026
Table 26. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 27. Global Natural Killer Cell Therapy Sales by Type (K Units)
Table 28. Global Natural Killer Cell Therapy Market Size by Type (M USD)
Table 29. Global Natural Killer Cell Therapy Sales (K Units) by Type (2020-2025)
Table 30. Global Natural Killer Cell Therapy Sales Market Share by Type (2020-2025)
Table 31. Global Natural Killer Cell Therapy Market Size (M USD) by Type (2020-2025)
Table 32. Global Natural Killer Cell Therapy Market Share by Type (2020-2025)
Table 33. Global Natural Killer Cell Therapy Price (USD/Unit) by Type (2020-2025)
Table 34. Global Natural Killer Cell Therapy Sales (K Units) by Application
Table 35. Global Natural Killer Cell Therapy Market Size by Application
Table 36. Global Natural Killer Cell Therapy Sales by Application (2020-2025) & (K Units)
Table 37. Global Natural Killer Cell Therapy Sales Market Share by Application (2020-2025)
Table 38. Global Natural Killer Cell Therapy Market Size by Application (2020-2025) & (M USD)
Table 39. Global Natural Killer Cell Therapy Market Share by Application (2020-2025)
Table 40. Global Natural Killer Cell Therapy Sales Growth Rate by Application (2020-2025)
Table 41. Global Natural Killer Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 42. Global Natural Killer Cell Therapy Sales Market Share by Region (2020-2025)
Table 43. Global Natural Killer Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 44. Global Natural Killer Cell Therapy Market Size by Region (2020-2025)
Table 45. North America Natural Killer Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 46. North America Natural Killer Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Europe Natural Killer Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 48. Europe Natural Killer Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 49. Asia Pacific Natural Killer Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 50. Asia Pacific Natural Killer Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 51. South America Natural Killer Cell Therapy Sales by Country (2020-2025) & (K Units)
Table 52. South America Natural Killer Cell Therapy Market Size by Country (2020-2025) & (M USD)
Table 53. Middle East and Africa Natural Killer Cell Therapy Sales by Region (2020-2025) & (K Units)
Table 54. Middle East and Africa Natural Killer Cell Therapy Market Size by Region (2020-2025) & (M USD)
Table 55. Global Natural Killer Cell Therapy Production (K Units) by Region(2020-2025)
Table 56. Global Natural Killer Cell Therapy Revenue (US$ Million) by Region (2020-2025)
Table 57. Global Natural Killer Cell Therapy Revenue Market Share by Region (2020-2025)
Table 58. Global Natural Killer Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. North America Natural Killer Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Europe Natural Killer Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Japan Natural Killer Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. China Natural Killer Cell Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. Nektar Therapeutics Basic Information
Table 64. Nektar Therapeutics Natural Killer Cell Therapy Product Overview
Table 65. Nektar Therapeutics Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 66. Nektar Therapeutics Business Overview
Table 67. Nektar Therapeutics SWOT Analysis
Table 68. Nektar Therapeutics Recent Developments
Table 69. Innate Pharma SA Basic Information
Table 70. Innate Pharma SA Natural Killer Cell Therapy Product Overview
Table 71. Innate Pharma SA Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 72. Innate Pharma SA Business Overview
Table 73. Innate Pharma SA SWOT Analysis
Table 74. Innate Pharma SA Recent Developments
Table 75. Affimed Basic Information
Table 76. Affimed Natural Killer Cell Therapy Product Overview
Table 77. Affimed Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Affimed Business Overview
Table 79. Affimed SWOT Analysis
Table 80. Affimed Recent Developments
Table 81. Chipscreen Biosciences Basic Information
Table 82. Chipscreen Biosciences Natural Killer Cell Therapy Product Overview
Table 83. Chipscreen Biosciences Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. Chipscreen Biosciences Business Overview
Table 85. Chipscreen Biosciences Recent Developments
Table 86. Glycostem Therapeutics Basic Information
Table 87. Glycostem Therapeutics Natural Killer Cell Therapy Product Overview
Table 88. Glycostem Therapeutics Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 89. Glycostem Therapeutics Business Overview
Table 90. Glycostem Therapeutics Recent Developments
Table 91. Fate Therapeutics Basic Information
Table 92. Fate Therapeutics Natural Killer Cell Therapy Product Overview
Table 93. Fate Therapeutics Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 94. Fate Therapeutics Business Overview
Table 95. Fate Therapeutics Recent Developments
Table 96. Dragonfly Therapeutics Basic Information
Table 97. Dragonfly Therapeutics Natural Killer Cell Therapy Product Overview
Table 98. Dragonfly Therapeutics Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 99. Dragonfly Therapeutics Business Overview
Table 100. Dragonfly Therapeutics Recent Developments
Table 101. Kiadis Pharma Basic Information
Table 102. Kiadis Pharma Natural Killer Cell Therapy Product Overview
Table 103. Kiadis Pharma Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Kiadis Pharma Business Overview
Table 105. Kiadis Pharma Recent Developments
Table 106. Nkarta Therapeutics Basic Information
Table 107. Nkarta Therapeutics Natural Killer Cell Therapy Product Overview
Table 108. Nkarta Therapeutics Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 109. Nkarta Therapeutics Business Overview
Table 110. Nkarta Therapeutics Recent Developments
Table 111. NantKwest Basic Information
Table 112. NantKwest Natural Killer Cell Therapy Product Overview
Table 113. NantKwest Natural Killer Cell Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 114. NantKwest Business Overview
Table 115. NantKwest Recent Developments
Table 116. Global Natural Killer Cell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 117. Global Natural Killer Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 118. North America Natural Killer Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 119. North America Natural Killer Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 120. Europe Natural Killer Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 121. Europe Natural Killer Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 122. Asia Pacific Natural Killer Cell Therapy Sales Forecast by Region (2026-2035) & (K Units)
Table 123. Asia Pacific Natural Killer Cell Therapy Market Size Forecast by Region (2026-2035) & (M USD)
Table 124. South America Natural Killer Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 125. South America Natural Killer Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 126. Middle East and Africa Natural Killer Cell Therapy Sales Forecast by Country (2026-2035) & (K Units)
Table 127. Middle East and Africa Natural Killer Cell Therapy Market Size Forecast by Country (2026-2035) & (M USD)
Table 128. Global Natural Killer Cell Therapy Sales Forecast by Type (2026-2035) & (K Units)
Table 129. Global Natural Killer Cell Therapy Market Size Forecast by Type (2026-2035) & (M USD)
Table 130. Global Natural Killer Cell Therapy Price Forecast by Type (2026-2035) & (USD/Unit)
Table 131. Global Natural Killer Cell Therapy Sales (K Units) Forecast by Application (2026-2035)
Table 132. Global Natural Killer Cell Therapy Market Size Forecast by Application (2026-2035) & (M USD)
List of Figures
Figure 1. Product Picture of Natural Killer Cell Therapy
Figure 2. Global Natural Killer Cell Therapy Market Size (M USD) (2020-2035)
Figure 3. Global Natural Killer Cell Therapy Sales (K Units) & (2020-2035)
Figure 4. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 5. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 6. Evaluation Matrix of Regional Market Development Potential
Figure 7. Company Assessment Quadrant
Figure 8. Global Natural Killer Cell Therapy Product Life Cycle
Figure 9. Natural Killer Cell Therapy Sales Share by Manufacturers in 2025
Figure 10. Global Natural Killer Cell Therapy Revenue Share by Manufacturers in 2025
Figure 11. Natural Killer Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 12. Global Market Natural Killer Cell Therapy Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 13. The Global 5 and 10 Largest Players: Market Share by Natural Killer Cell Therapy Revenue in 2025
Figure 14. Industry Chain Map of Natural Killer Cell Therapy
Figure 15. Natural Killer Cell Therapy Market Share of Key Raw Materials (2025)
Figure 16. Key Driving Factors - Impact Assessment
Figure 17. Market Challenges - Severity vs. Frequency Matrix
Figure 18. Key Industry News Timeline
Figure 19. PEST Analysis
Figure 20. Global Natural Killer Cell Therapy Market PEST Analysis
Figure 21. Global Natural Killer Cell Therapy Market Porter's Five Forces Analysis
Figure 22. Global Merchandise Trade as a Percentage Of GDP
Figure 23. US - lmports of Goods by Country
Figure 24. China Exports by Country
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Natural Killer Cell Therapy Market Share by Type
Figure 27. Sales Market Share of Natural Killer Cell Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Natural Killer Cell Therapy by Type in 2025
Figure 29. Market Share of Natural Killer Cell Therapy by Type (2020-2025)
Figure 30. Market Share of Natural Killer Cell Therapy by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Natural Killer Cell Therapy Market Share by Application
Figure 33. Global Natural Killer Cell Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Natural Killer Cell Therapy Sales Market Share by Application in 2025
Figure 35. Global Natural Killer Cell Therapy Market Share by Application (2020-2025)
Figure 36. Global Natural Killer Cell Therapy Market Share by Application in 2025
Figure 37. Global Natural Killer Cell Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Natural Killer Cell Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Natural Killer Cell Therapy Market Size by Region (2020-2025)
Figure 40. North America Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Natural Killer Cell Therapy Sales Market Share by Country in 2024
Figure 42. North America Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. North America Natural Killer Cell Therapy Market Size by Country in 2024
Figure 44. U.S. Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 45. U.S. Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Canada Natural Killer Cell Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 47. Canada Natural Killer Cell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 48. Mexico Natural Killer Cell Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 49. Mexico Natural Killer Cell Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 50. Europe Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 51. Europe Natural Killer Cell Therapy Sales Market Share by Country in 2024
Figure 52. Europe Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Europe Natural Killer Cell Therapy Market Size by Country in 2024
Figure 54. Germany Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 55. Germany Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. France Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 57. France Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. U.K. Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 59. U.K. Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Italy Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 61. Italy Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 62. Spain Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 63. Spain Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 64. Asia Pacific Natural Killer Cell Therapy Sales and Growth Rate (K Units)
Figure 65. Asia Pacific Natural Killer Cell Therapy Sales Market Share by Region in 2024
Figure 66. Asia Pacific Natural Killer Cell Therapy Market Size by Region in 2024
Figure 67. China Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. China Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Japan Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Japan Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. South Korea Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 72. South Korea Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 73. India Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 74. India Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 75. Southeast Asia Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 76. Southeast Asia Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 77. South America Natural Killer Cell Therapy Sales and Growth Rate (K Units)
Figure 78. South America Natural Killer Cell Therapy Sales Market Share by Country in 2024
Figure 79. South America Natural Killer Cell Therapy Market Size and Growth Rate (M USD)
Figure 80. South America Natural Killer Cell Therapy Market Size by Country in 2024
Figure 81. Brazil Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 82. Brazil Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 83. Argentina Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 84. Argentina Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 85. Columbia Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 86. Columbia Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 87. Middle East and Africa Natural Killer Cell Therapy Sales and Growth Rate (K Units)
Figure 88. Middle East and Africa Natural Killer Cell Therapy Sales Market Share by Region in 2024
Figure 89. Middle East and Africa Natural Killer Cell Therapy Market Size and Growth Rate (M USD)
Figure 90. Middle East and Africa Natural Killer Cell Therapy Market Size by Region in 2024
Figure 91. Saudi Arabia Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 92. Saudi Arabia Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 93. UAE Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 94. UAE Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 95. Egypt Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 96. Egypt Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 97. Nigeria Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 98. Nigeria Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 99. South Africa Natural Killer Cell Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 100. South Africa Natural Killer Cell Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 101. Global Natural Killer Cell Therapy Production Market Share by Region (2020-2025)
Figure 102. North America Natural Killer Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Natural Killer Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Natural Killer Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. China Natural Killer Cell Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. Global Natural Killer Cell Therapy Sales Forecast by Volume (2020-2035) & (K Units)
Figure 107. Global Natural Killer Cell Therapy Market Size Forecast by Value (2020-2035) & (M USD)
Figure 108. Global Natural Killer Cell Therapy Sales Market Share Forecast by Type (2026-2035)
Figure 109. Global Natural Killer Cell Therapy Market Share Forecast by Type (2026-2035)
Figure 110. Global Natural Killer Cell Therapy Sales Forecast by Application (2026-2035)
Figure 111. Global Natural Killer Cell Therapy Market Share Forecast by Application (2026-2035)